BridgeMD
New treatment option for Myocardial Infarction
Official title Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction
ClinicalTrials.gov ID: NCT00794001
What this study is testing
- What it's testing
- Part I (Pilot Phase): The purpose of this study is to examine if formalized data assessment and systematic feedback improves treatment times (i.e. contact-to-balloon time and door-to-balloon time) in patients with myocardial infarction with ST-segment elevation (STEMI).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- all patients who received a diagnosis of STEMI\ and were transported to the cardiac catheterization laboratory of the primary PCI center with the...
- STEMI definition:
- elevation of the ST-segments of greater than or equal to 0.1 mV in at least two contiguous limb- or precordial leads
- new or presumable new left bundle branch block in the presence of typical symptoms
You likely can't join if
- STEMI-patients with duration of infarct-related symptoms longer than 24 hours are excluded
The study team makes the final eligibility decision.
Where it's taking place
- Hildesheim, Lower Saxony, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hildesheim, Lower Saxony, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.